Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports and stock price the company's current Operating Margin is 18.78%. At the end of 2024 the company had an Operating Margin of 18.79%.
Year | Operating Margin | Change |
---|---|---|
2024 | 18.79% | 6.22% |
2023 | 17.69% | -26.92% |
2022 | 24.20% | -0.63% |
2021 | 24.36% | 21.93% |
2020 | 19.98% | -5.4% |
2019 | 21.12% | -4.29% |
2018 | 22.06% | -4.56% |
2017 | 23.12% | -16.08% |
2016 | 27.55% | 0.56% |
2015 | 27.39% | -0.98% |
2014 | 27.66% | 27.51% |
2013 | 21.69% | 5.87% |
2012 | 20.49% | 7.8% |
2011 | 19.01% | -30.92% |
2010 | 27.52% | 8.11% |
2009 | 25.45% | -4.15% |
2008 | 26.56% | 22.15% |
2007 | 21.74% | -20.52% |
2006 | 27.36% | 5.35% |
2005 | 25.97% | -0.3% |
2004 | 26.04% | 5.77% |
2003 | 24.62% | -3.8% |
2002 | 25.60% | 4.74% |
2001 | 24.44% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | 12.60% | -32.91% | ๐บ๐ธ USA |
![]() Merck MRK | 31.06% | 65.39% | ๐บ๐ธ USA |
![]() Novartis NVS | 28.02% | 49.20% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | 15.12% | -19.49% | ๐ซ๐ท France |
![]() Stryker Corporation SYK | 14.35% | -23.59% | ๐บ๐ธ USA |
![]() Medtronic MDT | 14.94% | -20.45% | ๐ฎ๐ช Ireland |
![]() Eli Lilly LLY | 27.75% | 47.76% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | 17.36% | -7.56% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 13.32% | -29.07% | ๐ฌ๐ง UK |
![]() Gilead Sciences GILD | 23.75% | 26.46% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.